Rowlandmiller & Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Hold |
264
| – | – | 0.02% | 181 |
|
|
2025
Q1 | $131K | Hold |
264
| – | – | 0.03% | 164 |
|
|
2024
Q4 | $137K | Buy |
264
+30
| +13% | +$15.6K | 0.03% | 162 |
|
|
2024
Q3 | $145K | Hold |
234
| – | – | 0.03% | 156 |
|
|
2024
Q2 | $129K | Hold |
234
| – | – | 0.03% | 158 |
|
|
2024
Q1 | $136K | Hold |
234
| – | – | 0.03% | 158 |
|
|
2023
Q4 | $124K | Hold |
234
| – | – | 0.03% | 163 |
|
|
2023
Q3 | $118K | Sell |
234
-4
| -2% | -$2.03K | 0.03% | 161 |
|
|
2023
Q2 | $124K | Buy |
238
+4
| +2% | +$2.09K | 0.03% | 168 |
|
|
2023
Q1 | $135K | Hold |
234
| – | – | 0.03% | 162 |
|
|
2022
Q4 | $129K | Hold |
234
| – | – | 0.03% | 163 |
|
|
2022
Q3 | $119K | Buy |
234
+4
| +2% | +$2.03K | 0.03% | 162 |
|
|
2022
Q2 | $125K | Hold |
230
| – | – | 0.03% | 159 |
|
|
2022
Q1 | $136K | Hold |
230
| – | – | 0.03% | 158 |
|
|
2021
Q4 | $153K | Buy |
+230
| New | +$153K | 0.03% | 157 |
|
|
2021
Q3 | – | Sell |
-230
| Closed | -$116K | – | 183 |
|
|
2021
Q2 | $116K | Hold |
230
| – | – | 0.03% | 169 |
|
|
2021
Q1 | $105K | Hold |
230
| – | – | 0.03% | 163 |
|
|
2020
Q4 | $107K | Buy |
+230
| New | +$107K | 0.03% | 160 |
|